A metastatic nude-mouse model of human pancreatic cancer constructed orthotopically with histologically intact patient specimens.
about
PHD3 regulates differentiation, tumour growth and angiogenesis in pancreatic cancerPatient-derived tumour xenografts as models for oncology drug developmentTargeting LKB1 in cancer - exposing and exploiting vulnerabilitiesNeural Regulation of Pancreatic Cancer: A Novel Target for InterventionFluorescence-guided surgery in combination with UVC irradiation cures metastatic human pancreatic cancer in orthotopic mouse modelsColor-coding cancer and stromal cells with genetic reporters in a patient-derived orthotopic xenograft (PDOX) model of pancreatic cancer enhances fluorescence-guided surgeryTranslational validation of personalized treatment strategy based on genetic characteristics of glioblastomaComplementarity of ultrasound and fluorescence imaging in an orthotopic mouse model of pancreatic cancer.Extended-working-distance multiphoton micromanipulation microscope for deep-penetration imaging in live mice and tissueA reproducible brain tumour model established from human glioblastoma biopsiesGold nanoclusters-assisted delivery of NGF siRNA for effective treatment of pancreatic cancer.Liver colonization competence governs colon cancer metastasisCurrent status and perspectives of patient-derived xenograft models in cancer research.Development of orthotopic pancreatic tumor mouse modelsAdvantages of fluorescence-guided laparoscopic surgery of pancreatic cancer labeled with fluorescent anti-carcinoembryonic antigen antibodies in an orthotopic mouse model.Recombinant methioninase effectively targets a Ewing's sarcoma in a patient-derived orthotopic xenograft (PDOX) nude-mouse model.Molecular profiling of direct xenograft tumors established from human pancreatic adenocarcinoma after neoadjuvant therapy.The tumor-educated-macrophage increase of malignancy of human pancreatic cancer is prevented by zoledronic acid.Metastatic human hepatocellular carcinoma models in nude mice and cell line with metastatic potential.Combination treatment with TRA-8 anti death receptor 5 antibody and CPT-11 induces tumor regression in an orthotopic model of pancreatic cancerMetastatic recurrence in a pancreatic cancer patient derived orthotopic xenograft (PDOX) nude mouse model is inhibited by neoadjuvant chemotherapy in combination with fluorescence-guided surgery with an anti-CA 19-9-conjugated fluorophore.Evaluation of (89)Zr-labeled human anti-CD147 monoclonal antibody as a positron emission tomography probe in a mouse model of pancreatic cancer.Serial observations on an orthotopic gastric cancer model constructed using improved implantation technique.Influence of the implantation site on the sensitivity of patient pancreatic tumor xenografts to Apo2L/TRAIL therapy.Efficacy of tumor-targeting Salmonella typhimurium A1-R in combination with anti-angiogenesis therapy on a pancreatic cancer patient-derived orthotopic xenograft (PDOX) and cell line mouse models.Hand-held high-resolution fluorescence imaging system for fluorescence-guided surgery of patient and cell-line pancreatic tumors growing orthotopically in nude mice.Establishment of a patient-derived orthotopic Xenograft (PDOX) model of HER-2-positive cervical cancer expressing the clinical metastatic pattern.Fluorescence-guided surgery with a fluorophore-conjugated antibody to carcinoembryonic antigen (CEA), that highlights the tumor, improves surgical resection and increases survival in orthotopic mouse models of human pancreatic cancer.Knockdown of the β(1) integrin subunit reduces primary tumor growth and inhibits pancreatic cancer metastasis.Near infra-red photoimmunotherapy with anti-CEA-IR700 results in extensive tumor lysis and a significant decrease in tumor burden in orthotopic mouse models of pancreatic cancer.MUC1 selectively targets human pancreatic cancer in orthotopic nude mouse models.Imaging of primary and metastatic pancreatic cancer using a fluorophore-conjugated anti-CA19-9 antibody for surgical navigation.Metronomic gemcitabine in combination with sunitinib inhibits multisite metastasis and increases survival in an orthotopic model of pancreatic cancer.Ratiometric activatable cell-penetrating peptides label pancreatic cancer, enabling fluorescence-guided surgery, which reduces metastases and recurrence in orthotopic mouse models.Photoimmunotherapy lowers recurrence after pancreatic cancer surgery in orthotopic nude mouse models.Photoimmunotherapy Inhibits Tumor Recurrence After Surgical Resection on a Pancreatic Cancer Patient-Derived Orthotopic Xenograft (PDOX) Nude Mouse Model.MicroRNA-217 functions as a prognosis predictor and inhibits colorectal cancer cell proliferation and invasion via an AEG-1 dependent mechanism.Tumor-Targeting Salmonella typhimurium A1-R in Combination with Trastuzumab Eradicates HER-2-Positive Cervical Cancer Cells in Patient-Derived Mouse Models.Fluorescence-guided surgery, but not bright-light surgery, prevents local recurrence in a pancreatic cancer patient derived orthotopic xenograft (PDOX) model resistant to neoadjuvant chemotherapy (NAC)Characterization of gastric cancer models from different cell lines orthotopically constructed using improved implantation techniques.
P2860
Q24304449-F571E02F-7F38-459F-BC7F-A66D3BC79009Q24604068-0408B243-1539-4416-87C0-1FB2D3E41D56Q26801412-DF9DEAA6-5EEE-4D98-94DE-71C03861A337Q26801748-E7B26D84-71CB-4B0E-A0A5-F9420D58FAC2Q27323143-D2EF096B-F7DB-471B-8B74-504FBD4D6E38Q27325828-5126D8F6-D7EC-4515-8A5F-2D2DCF965315Q28541502-C3E56E3D-F91C-429C-8A87-B75C52159359Q33427677-E41DAA3E-DD19-4856-944B-3BD39E4D0C4CQ33437115-9653F017-7E90-4F4E-B1D9-F51CD6FFF9DFQ33521101-544A8885-7EDF-4E1B-A048-10A3067B6A3EQ33629373-D9D4E746-431E-4E2C-915F-A1E334CD17A3Q33646674-C3CC2CAD-3B09-467E-B5ED-185E5C9828FDQ33667686-D86E97B6-68FF-46F1-B991-E9D63C3E4C30Q33726528-1659D3A2-FDC5-460B-A71D-711C9F7A0D56Q33787300-67D00073-EBF3-4F16-B01A-0501B994F5F8Q33829258-99636442-894D-4C06-B686-CE77A580A640Q33956574-8452E4DF-4CB8-4F4A-8417-7E7EEBE8EF93Q34035071-F7918C36-3CEE-41E2-B2EA-8E92003AFED7Q34512125-3F4875DB-CD50-40B6-BF21-012C83165467Q34610496-E23DD497-05E8-425B-81D6-8055A4C6F556Q34612412-16A6052E-1DA1-4C59-A151-6D283D244F04Q34664176-A1128247-581B-44D5-8A6E-05ABF775E3CEQ34756752-A1629E5A-DAAC-46E1-8D4A-6681F33B3995Q35063836-EDDFA7FE-E0F2-4C28-9BE3-157341BA3BA7Q35067893-C460C3D8-E045-4294-8613-597EFF593D4DQ35077175-8CFF13C3-60B7-450F-9E9A-71397FFDBE05Q35090860-00840403-2AA4-475C-9DD4-50039CA5BFC3Q35101141-AE687273-E7C1-4AE8-92F4-AAA42962A0D0Q35199223-75547F7D-FF06-4CFF-A8D1-86FB5AE84FCDQ35208835-60FE9761-5844-4291-8B5E-02560DE87B1FQ35225232-710A6887-2438-4EEF-A420-C1891FDA108DQ35230680-11D0EA9D-98B2-435C-947A-1093AA220F93Q35247727-EF1DB7C4-4B72-4E4F-91E4-5CB14D2D76B9Q35335567-1538F671-B9EF-4EC5-A7D5-700606363BCFQ35584369-83C1E784-E0D8-40F5-8D83-D439BB105578Q35609687-99D29C85-6116-4654-A6F5-600ED097765DQ35643217-FEEFE257-CB3C-438B-B547-5BBBEF00E6BDQ35654559-4A6BBE76-706C-4162-9AB2-D22EC1822FD8Q35655968-78C58410-4ABC-462D-8AFD-B52FA240FE93Q35670446-AB266C3F-712B-42C8-B8A6-1D13004121F8
P2860
A metastatic nude-mouse model of human pancreatic cancer constructed orthotopically with histologically intact patient specimens.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 1992
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A metastatic nude-mouse model ...... ally intact patient specimens.
@en
A metastatic nude-mouse model ...... ally intact patient specimens.
@nl
type
label
A metastatic nude-mouse model ...... ally intact patient specimens.
@en
A metastatic nude-mouse model ...... ally intact patient specimens.
@nl
prefLabel
A metastatic nude-mouse model ...... ally intact patient specimens.
@en
A metastatic nude-mouse model ...... ally intact patient specimens.
@nl
P2093
P2860
P356
P1476
A metastatic nude-mouse model ...... ally intact patient specimens.
@en
P2093
P2860
P304
P356
10.1073/PNAS.89.12.5645
P407
P577
1992-06-01T00:00:00Z